InvestorBrandNetwork (IBN) Content Platform

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (“CLIA”) laboratory and Good Manufacturing Practices (“GMP”) facility to accelerate oncology drug discovery and enable drug development, is reporting on its Q2 2023 performance. The company reported financial and operating results for the three and six months ended June 30, 2023. Highlights of the report include the initiation of collaborations with PEDAL-Cancer Research Horizons for the analysis of drug compounds and with Cvergenx to identify novel molecules and compounds and the repurposing of radioprotective or radiosensitizing drugs; a presentation at the Bio International Convention focused on the importance of addressing patient heterogeneity in drug discovery and the advantages of leveraging active machine learning; and meetings with more than 30 biopharmaceutical development customer prospects along with further expansion of the company’ sales pipeline.

In addition, the company moved its corporate headquarters to Eagan, Minnesota, and established a new business advisory board with two members thus far and added a member to its board of directors. “We are very pleased with the steady progress that we have made since our last quarterly update, both advancing current PEDAL relationships with CRH, Cvergenx and others, while in parallel building our pipeline as more drug developers — both biopharmaceutical companies as well as research institutions — see the value that only Predictive Oncology can bring to the early drug-discovery process,” said Predictive Oncology CEO and chair Raymond F. Vennare in the press release. “With our unique set of assets and capabilities that clearly set us apart from other AI-focused drug discovery companies, including our extensive biobank of more than 150,000 tumor samples, combined with our CLIA lab, we can validate our predictions in wet-lab experiments in a setting that introduces patient heterogeneity into the earliest phases of drug discovery. We are the only company capable of doing this, and the results of these experiments can significantly increase the chances of later-stage clinical success by our customers.”

To view the full press release, visit https://ibn.fm/nAnha

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence (“AI”) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. With the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based, drug-discovery solutions, further complemented by its wholly owned CLIA lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, is reporting its financial results for the first quarter of 2024, the period ending June 30, 2023; the company also released a corporate update. Highlights of the report include positive top-line results from the company’s phase 3 PALISADE-2 trial of rapid-onset fasedienol (“PH94B”) nasal spray in social anxiety disorder (“SAD”); the staging of itruvone (“PH10”) nasal spray for phase 2B clinical development as a standalone, nonsystemic treatment for major depressive disorder (“MDD”); and optimism for the treatment of moderate to severe vasomotor symptoms, or hot flashes, in women experiencing menopause based on the positive exploratory phase 2A trial of VTGN’s PH80 (“PH80”) nasal spray. In addition, company Q1 2024 financial results show that R&D expenses decreased from $15.3 million to $4.2 million for the quarter; general and administrative expense decreased to $3 million from $4.8 million for the quarter ended June 20, 2022; net loss was approximately $6.9 million compared to $19.8 million for Q1 2022; and cash and cash equivalents for the company total approximately $9.6 million.

“The positive outcome of our PALISADE-2 study demonstrated that fasedienol significantly reduced the mean Subjective Units of Distress Scale score, reducing anxiety during a stressful public-speaking challenge,” said Vistagen CEO Shawn Singh in the press release. “The study outcome is a pivotal achievement for fasedienol and our diverse pherine platform. These results mark the first positive U.S. phase 3 study of an investigational therapy for social anxiety disorder in over 15 years. We believe these results reinforce the promise of our pherine pipeline to address growing unmet treatment needs. We now move forward confidently advancing the phase 3 program for fasedienol in SAD with planning for initiation of additional phase 3 studies in 2024. Our strong understanding of each pherine product candidate’s scientific and therapeutic potential gives us confidence in our ability to continue to innovate for patients and deliver long-term value for shareholders. With a collective body of positive safety and efficacy studies supporting our clinical-stage pipeline, we believe there are many strategic paths to accelerate our progress in achieving key clinical and regulatory milestones for each program over the next 12 months.”

To view the full press release, visit https://ibn.fm/lfa6D

About Vistagen Therapeutics Inc.

Vistagen Therapeutics is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than treatments that are currently available for treatment of anxiety, depression and multiple CNS disorders. Vistagen’s pipeline includes six clinical-stage product candidates, including fasedienol (“PH94B”), itruvone (“PH10”), PH15, PH80 and PH284, each an investigational agent belonging to a new class of drugs known as pherines, as well as AV-101, which is an oral prodrug antagonist of the N-methyl-D-aspartate receptor (“NMDAR”). Pherines are neuroactive nasal sprays designed with an innovative proposed mechanism of action that activates chemosensory neurons in the nasal cavity and can beneficially impact key neural circuits in the brain without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information about the company, please visit www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, will be presenting at this month’s Sidoti & Co. Micro Cap Virtual Conference. The two-day event is scheduled for Aug. 16–17, 2023. According to the announcement, PCSA’s president of research and development, David Young, will attend the conference and will present on Processa Pharmaceuticals at 11:30 a.m. ET on Aug. 17. In addition to Young’s presentation, company officials including CEO George NG will be available for one-on-one meetings with potential investors and other interested parties.

To view the presentation, visit https://ibn.fm/GaMaa

To view the full press release, visit https://ibn.fm/PnUzI

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing the next-generation chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also will increase the probability of FDA approval for its next-generation chemotherapy drugs following an efficient path to approval. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of drug-development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. Using its proven Regulatory Science Approach, the company has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGC drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients who will benefit from each NGC drug. Currently in the company pipeline are three NGC drugs: Next Generation Capecitabine (PCS6422 and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic and other cancers), Next Generation Gemcitabine (PCS3117 to treat pancreatic, lung, ovarian, breast and other cancers), and Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com. 

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000-plus points of distribution around the world, is reporting on its three-month and six-month performance, for the period ending June 30, 2023. Highlights for the quarter include a 140% increase in year-over-year revenue, which came in at $21.5 million; a 19% increase in gross profits, which totaled $4 million; and a net loss of $44.6 million, which includes the impact of impairment expenses of $34.9 million, losses on discontinued operations of $7.6 million, depreciation and amortization of $0.9 million and share-based compensation of $0.3 million. Year-to date highlights include an overall 210% increase in year-over-year revenue, which was $40.8 million; gross profit of $9.3 million, which represents a 68% year-over-year increase; and net loss of $48.5 million, which the report noted includes the impact of impairment expenses of $34.9 million, losses on discontinued operations of $8.3 million, depreciation and amortization of $1.7 million and share-based compensation of $1.0 million.

The company has scheduled a conference call hosted by senior management to discuss the report. The call is slated for Aug. 15, 2023, at 9 a.m. EST. Those interested can access the call by dialing toll-free 1-800-319-4610 (North America) or 1-604-638-5340 (international toll). “The second quarter marked a transitional phase for Flora,” said Flora Growth CEO Clifford Starke in the press release. “Our dedicated efforts were focused on cost reductions and resource optimization, the effects of which are expected to be felt in quarters to come. Throughout this rebuilding phase, we will continue to prioritize Flora as a leading consumer brand globally.”

To view the full press release, visit https://ibn.fm/x3w0E

About Flora Growth Corp.

Flora Growth is a consumer-packaged goods leader serving all 50 states with 20,000-plus points of distribution around the world. For more information about the company, please visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its second-quarter and half-year results for the period ended June 30, 2023. Highlights of the report include record daily mill throughput of 1,250 tonnes per day at Fox Complex, generating $6 million in cash gross profit during the quarter, with sustained higher throughput and improved grade expected to result in stronger production and margins in the coming months; a production increase of 54% at San José, with cash costs per ounce declining 24% compared to first quarter as the revised mine plan continues to be executed; higher mining rates and gold grades at Gold Bar, which is also reporting faster recovery and lower strip ratio from the Pick deposit, setting the stage for improved production and margins in the second half of 2023 and beyond; and progress being made toward a formal construction decision at the Fenix project, where a sonic drilling program has been initiated along with progress made on permitting applications and hiring a project manager. In addition, the company is reporting early retirement of $25 million, or 39%, of its outstanding debt during the second quarter with a safety track record of no lost-time incidents at its wholly owned operating mines.

“The year started with operational challenges at both Gold Bar and San José,” said McEwen Mining chair and chief owner Rob McEwen in the press release. “San José appears to have turned the corner, and we are confident that the plan in place for Gold Bar will do the same. Fox Complex has delivered another solid quarter, and we expect even better results in the second half of the year. We thank our operating teams for their hard work. The story at Los Azules keeps getting better and better. With a strong financing, an updated Preliminary Economic Assessment (‘PEA’) showing robust economics, unparalleled partners in Rio Tinto (through Nuton) and Stellantis, and potentially game-changing copper leaching technology, we could see Los Azules provide a model for how the mine of the future should look.”

To view the full press release, visit https://ibn.fm/TxYTx

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 52% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. McEwen Mining chair and chief owner Rob McEwen has a personal investment in the company of $220 million; his annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Breezer (OTC: BRZV), a trailblazer in the luxury lifestyle branding market, is aiming to revolutionize the liquor industry. The company today announced the launch of its exclusive corporate website at www.MagnumFinestSpirits.com, which was meticulously designed to showcase its heritage, products, community and expertise. It also upholds the most stringent disclosure standards, providing investors with easy access to the company’s filings with the Securities and Exchange Commission (“SEC”), up-to-the-minute stock quote and price data, and its vibrant social media channels. “Breezer Ventures isn’t just a corporate entity; it’s a vision,” said Breezer’s CEO Freddy Figueroa. “A vision fueled by the Tiller family’s unparalleled distilling heritage, documented back to 1731, and fully deployed for the 21st century. Their age-old family recipes, combined with Magnum 1770’s modern approach, are the cornerstones of our brand. We’re on a mission to elevate Magnum 1770, pushing boundaries and transcending the traditional realm of boxed lifestyle products.”

To view the full press release, visit https://ibn.fm/xiBXg

About Breezer Ventures Inc. / Magnum Finest Spirits Inc.

Magnum is a distilled spirits and marketing company offering products with a centuries-long history of outstanding quality. What separates Magnum from industry peers is its functionally innovative and environmentally conscious bag-in-a-box (“BiB”) packaging, and distinctive billboard style labeling. Never to be associated with discount or bulk, top shelf Magnum 1770 branded products include an exceptional bourbon, premium vodka, an esteemed gin, as well as trending flavored spirits. The company plans to expand on its relationships with the big box wine and liquor stores, warehouse liquor emporiums, traditional liquor stores, VIP and trending restaurants, bars, and nightclubs. Magnum has offices in Las Vegas, Nevada, and Murrieta, California. For more information, visit www.MagnumFinestSpirits.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

GlobalX (NEO: JET, JET.B) (OTCQB: JETMF) has closed the placement of $35 million of senior secured notes due in 2029 with funds managed by Axar Capital Management LP and its affiliates, a value-oriented alternative investment firm managing over $2.3 billion in assets. The proceeds from the notes will refinance all of the company’s existing indebtedness and provide GlobalX the capital required to continue to execute its growth plan and expand its passenger and freighter aircraft fleet from 11 aircraft to at least 16 by year-end 2023. ROTH MKM acted as joint placement agent for the placement.

To view the full press release, visit https://ibn.fm/x9R8y

About Global Crossing Airlines Group Inc.

GlobalX is a U.S. 121 domestic flag and supplemental airline flying the Airbus A320 family aircraft. GlobalX flies as a passenger ACMI and charter airline serving the U.S., Caribbean, European and Latin American markets. GlobalX is also now operating ACMI cargo service flying the A321 freighter. For more information, visit www.GlobalXAir.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, announced the pricing of its current public offering. The offering consists of up to 4,615,385 shares of the company’s common stock and warrants for purchase at $0.65 per share. According to the announcement, the warrants, which will expire on Oct. 10, 2028, will be immediately exercisable at an exercise price of $0.65 per share. The company anticipates gross proceeds from the offering to be approximately $3 million, before deductions such as placement agent fees and other offering expenses. The offering should close on or about Aug. 14, 2023, and will be subject to customary closing conditions. 180 Life Sciences expects to use the funds from the offering for R&D expenses as well as general corporate purposes, including the preparation of a marketing authorization application for Dupuytren’s Contracture and legal expenses. A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.

To view the full press release, visit https://ibn.fm/7Y8E2

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research and, where appropriate, combination therapy. The company’s current primary focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has retained the services of Clarivate(TM), a leading global provider of information services including IP lifecycle management solutions. Under the agreement, Clarivate will manage, maintain and track Silo Pharma’s intellectual property assets and technology rights, and serve as an advisor for strategic IP and patent expansion in support of pipeline development. “Our new agreement with Clarivate gives us the opportunity to step up our intellectual property and patent expansion efforts and reinforce protection for our novel assets under development,” said Eric Weisblum, chief executive officer of Silo Pharma. “Clarivate’s IP intelligence solutions will provide insights and clarity to inform our pursuit of future opportunities.”

To view the full press release, visit https://ibn.fm/qS9H4

About Silo Pharma Inc.

Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products, today announced that its OEM manufacturer, Global Safe Tracks, has received its first production run and started shipping units into Germany and the U.K. An additional 1,000 devices are going into production based on the initial positive feedback and forecast. Global Safe Tracks is licensed to manufacture a modified version of the GPS SmartSole that includes 2G technology as a fall back to 4G technology for countries where 4G coverage has not been fully implemented. “Since announcing our manufacturing partnership last week , we have seen immediate benefits across the supply chain,” said MetAlert CEO Patrick Bertagna. “By having an extra factory and point of distribution in Germany, we were able to fill orders for the U.K. within days, saving time and freight costs, back orders from Germany were quickly filled, saving time and costs, which then prompted an additional 1,000 units to go into production, as customer were seeing the improvements in our ability to ship orders. During the same time frame, we received a shipment from our U.S. factory and orders were immediately shipped out to our U.S. customers.”

To view the full press release, visit https://ibn.fm/ACW90

About MetAlert Inc.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling and licensing products, services and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer’s, dementia and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. Utilizing the latest in miniaturized, low power consumption GPS, cellular, RF, NFC, and BLE technologies, enabling caregivers to track and monitor patients in real time. MetAlert is known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information, visit the company’s website at www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a global vendor of Push-to-Talk (“PTT”) over Cellular (“PoC”) and cellular signal booster solutions, announced the newest member of its board of directors. The company has appointed Gary Herman to the board; he will replace Michael Kron. According to the announcement, Herman has garnered several decades of experience as a public company investor, fund manager and investment banker. He has also served as a corporate officer, capital raiser and restructuring specialist, and has also been on boards for both public and private companies; he is currently a board member for Jupiter Wellness Inc. (NASDAQ: JUPW), XS Financial Inc. (CSE: XS) and SusGlobal Energy Corp. (OTCQB: SNRG). “Gary’s deep experience as a public company board member and investor will add a tremendous resource to our board of directors,” said Siyata Mobile board chair Peter Goldstein in the press release. “His knowledge and expertise, along with his broad experience spanning many different industries and geographies will add valuable leadership and investment acumen as we continue to build a Board that is shareholder return focused.”

To view the full press release, visit https://ibn.fm/VPUH1

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation, Push-to-Talk over cellular devices, cellular booster systems and video-monitoring systems. Its portfolio of in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. The company’s portfolio of enterprise-grade and consumer cellular-booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. For its video monitoring system, Siyata integrates software licensed with off-the-shelf hardware providing customers with an integrated advanced camera system for management and visual monitoring of their fleet vehicles. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Motobyo, a burgeoning automotive e-commerce powerhouse, has announced a live webinar slated for Aug. 22, 2023, at 2 p.m. ET. The webinar, which is for accredited investors, will include an in-depth discussion about the key role auto dealers play in the Motobyo ecosystem and how auto dealers support the business model. Hosting the live event will be Motobyo CEO and founder George Lekas and premier dealer partner and High Street Auto Connection president Anthony Gasparro. According to the announcement, Motobyo is seeking accredited investors to join the company in changing the way that more than 40 million used-car transactions are completed each year. With its powerful asset-free business model that eliminates industry inefficiencies and connects supply directly to demand, Motobyo offers a unique opportunity to capitalize on the shifting dynamics of the $1.6 trillion used-car market. The company has recently raised a $2.5 million seed round of capital to support its launch and created 3,000 accounts in 48 states, with monthly account sign-ups increasing by 300% since Jan. 1, 2023.

To view the webinar, visit https://ibn.fm/wLTEe

To view the full press release, visit https://ibn.fm/KWE9r

About Motobyo

Motobyo, a private-party online automotive marketplace, utilizes a patent-pending pricing technology that allows its one-of-a-kind platform to deliver the most comprehensive solutions for private consumers looking to buy or sell a vehicle. Motobyo has raised the bar with “Instant Cash Offers” and guaranteed sales, as well as other products and services typically only provided by dealerships. For more information about the company, please visit www.Motobyo.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced financial results for the second quarter 2023 and provided a corporate and commercial update. “During the second quarter, we saw a continuation of the many positive trends that have contributed to our improved financial profile, including growing revenue contribution from highly scalable business-to-business (‘B2B’) customers, expanding gross margins, and reduced operating expenses as compared to the same period last year,” said Erez Raphael, chief executive officer of Dario. “Of note, we increased our gross profit margin to 33.7% in the second quarter of 2023 compared to 18.4% in the second quarter of 2022. Our proforma gross margins increased to 51.5% in the second quarter of 2023, up significantly from 36.1% in the second quarter of 2022, while reducing our operating expense run rate by 13% over that period.”

To view the full press release, visit https://ibn.fm/ZuPf8

About DarioHealth Corp.

DarioHealth is a leading digital health company, revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Its platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. Dario’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and directly to consumers. To learn more about Dario and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its second-quarter and half-year results for the period ended June 30, 2023. Highlights of the report include record daily mill throughput of 1,250 tonnes per day at Fox Complex, generating $6 million in cash gross profit during the quarter, with sustained higher throughput and improved grade expected to result in stronger production and margins in the coming months; a production increase of 54% at San José, with cash costs per ounce declining 24% compared to first quarter as the revised mine plan continues to be executed; higher mining rates and gold grades at Gold Bar, which is also reporting faster recovery and lower strip ratio from the Pick deposit, setting the stage for improved production and margins in the second half of 2023 and beyond; and progress being made toward a formal construction decision at the Fenix project, where a sonic drilling program has been initiated along with progress made on permitting applications and hiring a project manager.

In addition, the company is reporting early retirement of $25 million, or 39%, of its outstanding debt during the second quarter with a safety track record of no lost-time incidents at its wholly owned operating mines. “The year started with operational challenges at both Gold Bar and San José,” said McEwen Mining chair and chief owner Rob McEwen in the press release. “San José appears to have turned the corner, and we are confident that the plan in place for Gold Bar will do the same. Fox Complex has delivered another solid quarter, and we expect even better results in the second half of the year. We thank our operating teams for their hard work. The story at Los Azules keeps getting better and better. With a strong financing, an updated Preliminary Economic Assessment (‘PEA’) showing robust economics, unparalleled partners in Rio Tinto (through Nuton) and Stellantis, and potentially game-changing copper leaching technology, we could see Los Azules provide a model for how the mine of the future should look.”

To view the full press release, visit https://ibn.fm/TxYTx

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 52% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. McEwen Mining chair and chief owner Rob McEwen has a personal investment in the company of $220 million; his annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tingo Group (NASDAQ: TIO), a profitable and fast-growing fintech and agrifintech company, has changed the date it plans to file form 10-Q for the second quarter, the period ending June 30, 2023. According to the announcement, the company has rescheduled the date for Aug. 21, 2023. The results will be shared during a second-quarter 2023 conference call and webcast scheduled for 8 a.m. ET; a press release will also be released with the information. Those interested in participating in the conference call, along with the Q&A segment, may dial toll-free 1-877-704-4453 or 1-201-389-0920 (internationally), then enter conference code 13739698. A replay of the call will be available through Sept. 21, 2023, by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and entering replay pin number 13739698. The postponement will allow independent counsel, which has been retained by Tingo’s independent directors, time to complete an independent review of the allegations made in the Hindenburg short-seller report. “Tingo’s independent directors believe it is in the best interest of both the company and its shareholders for the independent directors to receive the report of the independent review ahead of the company hosting its earnings call and issuing the company’s results for the second quarter ended June 30, 2023,” the announcement stated. ‘

To view the webcast, visit https://ibn.fm/m0S3g

To view the full press release, visit https://ibn.fm/38Ftg

About Tingo Group Inc.

Tingo Group is a global fintech and agrifintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device-as-a-service” smartphone and a service-added platform. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services such as the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that is currently in beta version and offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• GolfLync’s growth in members (15x in the past 4 months) is reminiscent of early-stage growth for companies like FaceBook (NASDAQ: META) and SnapChat (NYSE: SNAP)
• GolfLync’s membership conversion underscores its strength in the marketplace and ability to create innovative platform features users want
• GolfLync is growing because it understands how to create thriving online communities that connect its members together around their passion sport, GOLF

When it comes to new social media apps, the difference between hype and reality is seen in the numbers. GolfLync, a new and fast-growing social networking platform for golfers, has already garnered over 45,000 downloads, growing its member base more than 15x in just the past 4 months.

In comparison with other social media companies, GolfLync (available for download on the Apple App Store and the Google Play Store) has a top 25% conversion rate in its peer group (Social Networking) as…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, has unveiled its coyni Mobile Point of Sale (“mPOS”) app. The new app enables iOS and Android devices to become POS terminals for merchants needing secure, efficient transactions. According to the announcement, the coynie mPoS app can be downloaded in beta mode from the Apple and Google stores. The new app enables merchants to accept contactless payments in person while ensuring seamless and secure transactions. The app, which is highly scalable to support a large number of terminals and users, creates unique QR codes that customers can scan and then use to pay, eliminating the need for merchants to use card readers. In addition, the app can process using customized business rules such as predefined percentages, dollar-based tips and consumer-specified amounts at the terminal level while also providing data insights and functionality.

“We are thrilled to announce the launch of coyni mPOS, which is a testament to the future success of the coyni platform and our dedication to its continued growth. This aligns with our overall strategy of creating value and brings us one step closer to our vision of spinning off coyni,” said RYVYL CEO and cofounder Fredi Nisan in the press release. “By integrating mPOS capabilities with the coyni platform, businesses and merchants can benefit from a comprehensive and user-friendly payment system coupled with the rounded foundation of the next beta release of the coyni business platform. Transactions can be executed with confidence using reliable and secure blockchain technology with each coyni digital token held in a wallet on the platform matched with one U.S. dollar held in a custodial account with a federally insured financial institution. The coyni platform can be utilized by both consumers and businesses for a wide range of payment purposes.”

To view the full press release, visit https://ibn.fm/Y84XW

About RYVYL

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business and peer-to-peer payment transactions around the globe. By leveraging unique blockchain security and USD-pegged stablecoin technology with near real-time attestation, RYVYL is reinventing the future of financial transactions using its coyni(R) stablecoin platform as a transactional foundation. Since its founding as GreenBox POS in 2017, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity-theft protection and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information about the company, please visit www.RYVYL.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services (OTCQB: SHRG) is a company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. Its subsidiary and leading producer and distributor of nootropic, functional beverage products, The Happy Co., recently unveiled a new limited-time seasonal flavor for its popular energy drink PerX and also launched a new probiotic dietary supplement product called Probio8. “Called Tropical Twist, the new PerX is a cool and refreshing energy drink designed to be ‘your neXt-level nootropic beverage.’ The Happy Co. initially announced its PerX brand in January 2023, and since then the energy drink has become one of the most popular choices in the company’s product offerings… In addition to its Tropical Twist announcement, SHRG’s The Happy Co. has launched a new probiotic dietary supplement product: Probio8. This gluten-free, sugar-free and vegan capsule offering contains eight different strains of beneficial probiotics, prebiotics and postbiotics, with each daily dose containing up to 23 billion healthy bacteria,” explains a recent article. “We’re committed to always expanding and improving what we do. Probio8 is a great example of how, even with our best products, we’re always looking for opportunities to innovate and to serve our customers better,” Sharing Services CEO John “JT” Thatch is quoted as saying.

To view the full article, visit https://ibn.fm/4wWGZ

About Sharing Services Global Corporation

Sharing Services is a publicly traded diversified company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. Additional information is contained in the company’s 10-Q and 10-K filings with the Securities and Exchange Commission. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries, today announced strongly accelerating orders for its UltraShear(TM)-processed Nano-CBD topical spray product. According to the update, the company has received seven initial market-seeding orders for UltraShear Nano-CBD from five new and two existing distributors in the three weeks following PBIO’s expansion into phase 2 of its commercial roll out.

“As previously explained, we strongly believe the marketplace has long been looking for a higher quality, effective, suitably nanoemulsified CBD product that can finally deliver fast and potent topical absorption of targeted benefits to users. The immediate response received from knowledgeable and experienced distributors, once they have been introduced to UltraShear Nano-CBD, has fully confirmed our expectations – they quickly ask for the opportunity to market our UltraShear-processed product,” said John B. Hollister, director of marketing and sales. “We are confident that the powerfully differentiated consumer experience will provide the all-important adoption driver complementing our sales and marketing efforts. Our team will be attending multiple key industry meetings to facilitate greater UltraShear exposure to key CBD industry players and to add additional distributors. Our goal is to expand to 25 distributors prior to year-end and 50 within 12 months. We believe each distributor will generate hundreds of thousands of dollars in annual revenue. Five new distributors and $300,000 in incremental revenue has been a gratifying start in the three-week period since launching our accelerated roll-out phase, but we believe it is just the ‘tip of the iceberg.’”

To view the full press release, visit https://ibn.fm/d05Qy

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. Its products utilize both constant and alternating pressure. The company’s patented enabling technology platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control bio-molecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterrorism applications. The company has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing it to enter the bio-pharma contract services and GMP manufacturing equipment sector. The company has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) (UltraShear(TM)) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has announced plans to report its Q1 2024 financial results. In conjunction with that, the company will also host a corporate conference call. According to the announcement, the company has scheduled to call on Aug. 10, 2023, at 4:30 p.m. ET. During the call, company leaders will provide a corporate update and release financial results for its fiscal year 2024 first quarter, the period ended June 30, 2023. Those interested in participating on the call can dial toll-free 1-800-954-1051 in the United States or 1-212-231-2924 internationally, then use conference ID 22027732. The company noted that a replay of the call will be available. Those interested in accessing the replay can dial toll-free 1-844-512-2921 within the United States or 1-412-317-6671 internationally, then use replay access ID number 22027732.

To view the webcast, visit https://ibn.fm/MnFvJ

To view the full press release, visit https://ibn.fm/EloQ1

About Vistagen Therapeutics Inc.

Vistagen Therapeutics is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than treatments that are currently available for treatment of anxiety, depression and multiple CNS disorders. Vistagen’s pipeline includes six clinical-stage product candidates, including fasedienol (“PH94B”), itruvone (“PH10”), PH15, PH80 and PH284, each an investigational agent belonging to a new class of drugs known as pherines, as well as AV-101, which is an oral antagonist of the N-methyl-D-aspartate receptor (“NMDAR”). Pherine dose nasal sprays and can beneficially impact key neural circuits in the brain without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information about the company, please visit www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, is reporting its unaudited financial results for the second quarter ended June 30, 2023. Highlights of the report include revenues of $75.2 million, operating costs of $47.7 million, Adjusted EBITDA of $27.6 million, and net income of $24.4 million. The report also noted that the Average Revenue Per Daily Active User (“ARPDAU”) reached $1.05, up from $0.95 in the second quarter of 2022, and the average monthly revenue per payer was $235 for the quarter, up from $226 in the same quarter of 2022. “Our business performed well in the second quarter as Adjusted EBITDA increased more than 10% year over year and we generated approximately $38 million in operating cash flow, excluding the final litigation settlement payment,” said DoubleDown Interactive CEO In Keuk Kim in the press release.

“ARPDAU and average monthly revenue per player rose 11% and 4%, respectively, compared to the second quarter of 2022. DoubleDown’s attractive business model combined with our disciplined focus on managing operating expenses delivers solid Adjusted EBITDA margins as demonstrated by the 34.7% margin through the first six months of 2023, a 290-basis point improvement over the comparable period in 2022. Our ability to consistently generate positive cash flow, combined with our strong balance sheet with more than $150 million in uncommitted capital, provides us with the flexibility to invest in new gaming categories and high addressable market opportunities such as iGaming through our pending acquisition of SuprNation, which is expected to close later this year. We are encouraged by our performance in the first half of the year and expect to continue generating attractive cash flow over the balance of 2023 and beyond.”

To view the full press release, visit https://ibn.fm/R9Mlg

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information about this company, please visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a global vendor of Push-to-Talk (“PTT”) over Cellular (“PoC”) and cellular signal booster solutions, announced that shareholders approved all proposals presented at the company’s Annual and Special Meeting of Shareholders, including a reverse stock split. Following that approval, Siyata announced it will effect a 1-for-100 reverse stock split of its common share, no par value per share, effective tomorrow, Aug, 9, 2023; the company’s common shares will start trading on NASDAQ on a post-split basis at the opening of the market tomorrow as well. The company noted that the objective of the reverse stock split is primarily to bring the company into compliance with the $1 minimum bid price requirement for maintaining its listing on NASDAQ. The company held its Annual and Special Meeting of Shareholders on Aug. 3, 2023. In addition to the reverse stock split, shareholder approved other proposals, including the appointment of Barzily & Co. as the auditor of the company for the ensuing year; fixing the number of directors of the company at five; the election of directors; and the consideration and approval of ordinary resolutions authorizing and approving an alteration to the articles of the company.

To view the full press release, visit https://ibn.fm/ISNYV

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation, Push-to-Talk over cellular devices, cellular booster systems and video-monitoring systems. Its portfolio of in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. The company’s portfolio of enterprise-grade and consumer cellular-booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. For its video monitoring system, Siyata integrates software licensed with off-the-shelf hardware providing customers with an integrated advanced camera system for management and visual monitoring of their fleet vehicles. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Lottery.com (NASDAQ: LTRY, LTRYW) today announced the successful conclusion of its 2023 Annual Meeting of Stockholders, held in a virtual-only format. According to the announcement, the meeting yielded significant positive outcomes, instilling confidence in Lottery.com’s trajectory and tremendous support for its vision. “The overwhelming support from our shareholders for the reverse stock split is a very important milestone in the transformation of our company. With these positive developments, we are poised to attract new opportunities and unlock greater potential for our business,” said Matthew McGahan, Lottery.com’s board chairman and interim CEO. “The board’s decision to remove the ‘option to purchase Sports.com’ from the UCIL agreement has created a significant boost in confidence for the company, its team, shareholders, and investors, reaffirming UCIL’s dedication to generating value for all stakeholders. We are immensely grateful for the trust and confidence our shareholders have placed in us.”

To view the full press release, visit https://ibn.fm/lAvmr

About Lottery.com

Lottery.com is a leading technology company that is transforming how, where and when lotteries are played. Its engaging mobile and online platforms enable players and commercial partners located throughout the United States and other countries to remotely purchase safe and legally sanctioned lottery games. Lottery participants look to the company’s website, Lottery.com, for compelling, real-time results on over 800 lottery games from over 40 countries. In all that it does, Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives.

NOTE TO INVESTORS: The latest news and updates relating to LTRY are available in the company’s newsroom at https://ibn.fm/LTRY

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TruPlay Games, a Christian entertainment company that creates transformative content for children, announced that it is launching a platform that offers “games, comics and cartoons designed to bring God’s truth to its youngest consumers. In a world of toxic content for children, TruPlay brings inspiration and hope to the youngest generation and is a safe and trusted platform for children to explore multiple games all in one app.” According to the announcement, the company offers beautiful, fun and inspiring digital experiences that are created by industry-leading veterans; the offerings have no ads, in-app purchases or chat features, providing an opportunity for children to experience nontoxic multimedia experiences that strengthen their faith. TruPlay’s digital entertainment platform is available on phones and tablets on Apple iOS and Google Android nationwide and is a subscription service. “We’re parents just like you who care about our children’s future, mental health and souls,” said TruPlay Games founder and CEO Brent Dusing in the press release. “Parents make the best parents. By supporting TruPlay, you’ll see more Christian content that will affirm your values and lead to a change for an entire generation of children.”

To view the full press release, visit https://ibn.fm/v4iKh

About TruPlay Games

TruPlay Games is committed to its mission to transform generations of children in such a profound way that it will shape culture. TruPlay is building a beautiful, fun, world-class entertainment platform that invites children into a world of hope and God’s truth. For more information, visit the company’s website at www.TruPlayGames.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Adamas (NASDAQ: JEWL), The Original Lab-Grown Diamond Company(TM), is a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, lab-grown diamonds for jewelry and diamond materials for industrial uses. The company today announced its entry into a non-binding letter of intent (“LOI”) to acquire a key lab-grown diamond manufacturer, Flawless Allure Grown Diamonds, LLP (“FAGD”). “This acquisition will solidify our position as a leader in the lab-grown diamond industry based on our capabilities to vertically integrate, produce and market lab-grown diamonds,” said Adamas One CEO Jay Grdina. “Our goal has been to complete our ecosystem and become as self-sufficient as possible, and the acquisition of Flawless, one of the top diamond cut and polishers in the industry, completes our ability to control our end-to-end production, speed of production and time-to-marketing. This transaction represents a significant step in the execution of our strategy to ensure that we are well positioned in the market, with minimal to no shareholder dilution.”

To view the full press release, visit https://ibn.fm/3E5pq

About Adamas One Corp.

Adamas is a lab-grown diamond manufacturer that, in its facilities in Greenville, South Carolina, produces near flawless single-crystal diamonds for gemstone and industrial applications. The company holds 36 patents and uses its proprietary chemical vapor deposition (“CVD”) to grow gem-sized and smaller diamond crystals. Adamas One(TM) lab-grown diamonds have the same physical, chemical and optical properties as mined diamonds. The company’s controlled manufacturing processes enables it to produce very high-quality, high-purity, single-crystal colorless, near colorless and fancy colored Type IIA diamonds to suit a variety of industrial and gemstone applications. The company intends to market and sell its diamonds into the wholesale jewelry and industrial markets. For more information, visit www.AdamasOne.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Cheetah Net (NASDAQ: CTNT), a supplier of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, recently announced the closing of its initial public offering of 1,250,000 shares of Class A common stock. The company secured gross proceeds of $5.0 million, with each share of Class A common stock sold at an offering price of $4.00. In addition, Cheetah Net granted the underwriters a 45-day option to purchase up to an additional 187,500 shares of Class A common stock to cover over-allotments at the initial public offering price, less the underwriting discount. The Class A shares began trading under the symbol CTNT on the Nasdaq Capital Market on Aug. 1, 2023. Maxim Group LLC acted as sole book-running manager for the offering. Hunter Taubman Fischer & Li LLC acted as U.S. counsel to the company, and Loeb & Loeb LLP acted as U.S. counsel to Maxim Group LLC in connection with the offering.

To view the full press release, visit https://ibn.fm/HlAdl

About Cheetah Net Supply Chain Service Inc.

Cheetah Net is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the PRC market. In the PRC, parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers’ official distribution systems. To the company’s knowledge, there are currently no U.S. federal or state laws, regulations or rules on trade or export that prohibit the export of vehicles that will be parallel imported into foreign countries. The company purchases automobiles, primarily luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to the company’s customers, including both U.S. and PRC parallel-import car dealers. The company derives profits primarily from the price difference between the company’s buying and selling prices for parallel-import vehicles.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

GolfLync, the trailblazing social media platform designed exclusively for golf enthusiasts, has witnessed a meteoric 15x membership increase over the past four months. This achievement is further solidified by GolfLync’s outstanding performance, ranking in the top 75% percentile for APP store conversions within the social media category—a remarkable feat for a recently launched application. Building on the success of industry giants like Facebook (NASDAQ: META), Snapchat (NYSE: SNAP) and TikTok that harnessed the power of community engagement to achieve explosive growth, GolfLync’s visionary founders quickly trademarked Virtual Golf Clubs(TM) (“VGC”), swiftly expanding its features. With VGC, members are able to discover local golf communities and public clubs, finding like-minded individuals who share their passion for the sport. Fueled with an intelligent algorithm, the platform offers a personalized experience, connecting golfers based on location, interests and proficiency, including handicap and playing preferences.

To view the full press release, visit https://ibn.fm/BkfI1

About GolfLync Inc.

GolfLync is a leading social networking platform designed exclusively for golfers. With a focus on community building and user engagement, GolfLync connects golf enthusiasts, fosters vibrant virtual golf clubs, and enhances the overall golfing experience. GolfLync is available for download on the Apple App Store and the Google Play Store. For more information, visit www.GolfLync.com.

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a SaaS technology company focused on delivering mobile live dealer technology to global online gaming operators, has completed a systems integration with Pariplay(R), a subsidiary of NeoGames S.A (NASDAQ: NGMS). The integration is outlined in a two-year agreement and calls for Pariplay to add and market Playgon’s proprietary mobile-first live dealer and E-table offerings. A tier-one aggregator and content provider that services more than 150 operators with innovative products, Pariplay will provide Playgon’s offerings under its VegasLounge(TM) brand; the content will also be available in Pariplay’s content library for a global client base in regulated markets. Pariplay indicated that Playgon Games’ mobile live-dealer titles occupy a unique spot in the industry. “We’re delighted to be able to offer them across our operator network through the market-leading Fusion(R) platform,” said Pariplay officials, noting that it was another positive addition to the company’s portfolio and a real selling point for partners looking to target new demographics. “Completion of this integration with Pariplay will give us access to high-profile markets and new markets we are chasing through their aggregation platform,” said Playgon Games president and CEO Darcy Krogh in the press release. “We look forward to working with the team at Pariplay to onboard new operators and expect it to accelerate our growth as we build on our partnership.”

To view the full press release, visit https://ibn.fm/Nh4xj

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Playgon’s current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com.

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, today announced the expansion of its partnership with a large regional health plan to deliver highly personalized digital health solutions to plan members living with diabetes. The launch is anticipated to take place in the first quarter of 2024. “Our ability to engage members for long-term success and deliver real financial value continues to drive demand in the payer market, including among our existing clients,” said Rick Anderson, president of DarioHealth. “Dario is excited to expand our relationship with the plan and engage more of its members with our highly personalized support for multi-chronic health needs. We believe this further validates our multi-condition strategy, which allows us to create more value within each customer than point solutions by accessing a larger eligible population under additional conditions. It also demonstrates Dario’s ability to expand our offerings with health plans over time.”

To view the full press release, visit https://ibn.fm/BbaY6

About DarioHealth Corp.

DarioHealth is a leading digital health company, revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Its platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. Dario’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and directly to consumers. To learn more about Dario and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Golden Triangle Ventures (OTC: GTVH), a multifaceted financial news and publishing company for private and public entities, has begun sales on the Le Pragma CBD product line; GTVH recently acquired Le Pragma, an emerging brand dedicating to providing high-end health, wellness and beauty products to complement an active lifestyle. According to the announcement, Le Pragma’s line of full-spectrum tinctures is live on the company’s website (LePragma.com), and other product lines are being evaluated and tested before adding them to the site. Golden Triangle Ventures has developed a strategic plan to develop Le Pragma into a globally recognized brand.

The plan includes comprehensive data compilation and optimization; a revamped digital presence complete with real-time inventory accountability, order tracking and customer-engagement data; a proactive regulatory stance to develop a fully compliant and professional product offering designed to maintain brand reputation and consumer safety; an inventory management overhaul to improve logistics, reduce shipping times and enhance overall efficiency; in-depth product insights to allow management to make key adjustments to the formulation of the next round of products; and continued affiliate marketing initiatives and outreach as well as a reimagined social media presence. “Launching sales and officially acquiring the Le Pragma CBD product line is an achievement that resulted from years of preparation and an unwavering dedication to complete this goal because of the confidence our entire team has in its potential,” said Golden Triangle Ventures CEO Steffan Dalsgaard in the press release. “I believe this acquisition supports GTV’s overall strategy and will prove to be an extraordinary asset for the company.”

To view the full press release, visit https://ibn.fm/cOrJo

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company, which operates as the parent business pursuing ventures in the health, entertainment and technology sectors along with others that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators that have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors the company aims to do business in. Golden Triangle Ventures is highly focused on acquiring a well-diversified portfolio of companies under one umbrella, which are all managed and owned by the company. An amazing team of professionals support each division and continue to help Golden Triangle Ventures grow daily. Operating as a publicly traded company enables the ability to provide the support needed to help each subsidiary grow into the businesses that management believes they can and will become. For more information about the company, please visit www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

CISO Global Inc. (NASDAQ: CISO), has unveiled Argo Edge, a powerful tool stack the company has been developing and testing for the past two years. According to the announcement, Argo Edge combines the most sought-after security technologies available with CISO’s proprietary IP and threat feeds to provide a prebuilt, easy-to-implement solution created for use by both government and privately held entities. The new AI-powered security solution, which has been independently valued at $49 million, enhances cybersecurity effectiveness through coordination, integration and automation. The company stated that Argo Edge layers together preconfigured, preintegrated technologies that include cloud firewall as a service (“FaaS”), secure internet gateway, secure authentication, secure service edge (“SSE”) and containerized internet browser sessions for each user. Argo Edge also provides Zero Trust Network Access (“ZTNA”), Cloud Access Security Broker (“CASB”) and Data Loss Protection (“DLP”) capabilities along with overall improved network performance.

“We believe this valuation solidifies CISO Global as a growing leader in the cybersecurity industry, and that the solution’s capabilities validate the company’s ability to deliver on its mission to demystify and accelerate its clients’ journey to cyber resilience,” said CISO Global CEO David Jemmett in the press release. “Unlike most security platforms currently on the market that add complexity and increase the need for additional staff to manage them, Argo Edge leverages automation and preconfigures highly complex security processes.”

To view the full press release, visit https://ibn.fm/Ui8jE

About CISO Global Inc.

CISO Global is an industry leader as a managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CISO.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Breezer Ventures (OTC: BRZV) has unveiled an exclusive line of new gin products designed to complement its existing bourbon and ultra-premium vodka. The new product line is offered through Magnum Finest Spirits Inc., BRZV’s wholly owned subsidiary, and was developed in collaboration with Kalifornia Distilleries Inc. based on centuries-old recipes and 300 years of family distilling heritage. The new offering, Magnum 1770 Gin, features hints of juniper and contains a proprietary blend of natural botanicals. Consumers can choose from two packaging options: an innovative and ecoconscious 1.75l Bag in a Box (“BiB”) or stylish square bottles, either 750ml or 1.75l. The company is planning a variety of marketing campaigns along with special events and sponsorships; an official Magnum 1770 VIP Gin Launch Gala Party is also in the works. According to the announcement, Breezer Ventures is in the process of changing its name and ticker symbol to better reflect its focus on Magnum Finest Spirits Inc., a distilled spirits and marketing company with an exceptional line of products. The company will be filing with FINRA for approval to make the change. Magnum expects to release additional news regarding changes to its management team and new product launches in the coming months. “Our Magnum 1770 Gin has been developed over 300 years and recently perfected by our master distiller partners at Kalifornia Distilleries,” said Breezer CEO Freddy Figueroa in the press release.

To view the full press release, visit https://ibn.fm/doOjM

About Breezer Ventures Inc./Magnum Finest Spirits Inc.

Magnum is a distilled spirits and marketing company offering products with a centuries-long history of outstanding quality. What separates Magnum from industry peers is its functionally innovative and environmentally conscious Bag in a Box (“BiB”) packaging and distinctive billboard-style labeling. Never to be associated with discount or bulk, top-shelf Magnum 1770-branded products include an exceptional Bourbon, premium Vodka and an esteemed Gin, as well as trending Flavored Spirits. The company plans to expand on its relationships with the big box wine and liquor stores, warehouse liquor emporiums, traditional liquor stores, VIP and trending restaurants, bars and nightclubs. For more information about this company, please visit www.MagnumFinestSpirits.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has advanced the formulation development for its therapeutic drug, SPC-15. According to the update, formulation development was in accordance with the company’s sponsored research agreement and option with Columbia University, and the liquid nasal formulation will be used in SPC-15’s novel protocol intended for treatment and prevention of anxiety, PTSD and other stress-related disorders. “The progress of our feasibility study investigating dose strengths of SPC-15 is a significant advancement in our development work with this pipeline candidate,” said Eric Weisblum, chief executive officer of Silo Pharma. “Results of the feasibility study will determine our selection of the manufacturing processes, and we are currently in discussions with potential delivery partners. We may also use the feasibility data for upcoming studies related to our SPC-14 therapeutic targeting Alzheimer’s disease.”

To view the full press release, visit https://ibn.fm/RiwDj

About Silo Pharma Inc.

Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage pharmaceutical company focusing on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer. The company today announced its appointment of industry veteran George Ng to serve as its chief executive officer and as a board director as of Aug. 8, 2023. Dr. David Young will focus his efforts on the development of the Next Generation Chemotherapy (“NGC”) drugs as president of research and development and as a board member. “We are thrilled to have George assume the leadership of our management team. His extensive managerial experience and proficiency in issues and opportunities afforded small-cap publicly traded biotech companies makes him an ideal fit for our company and will ensure that we continue executing our strategy and create value for our stockholders,” said Processa’s Chairman Justin Yorke. “Late last year, we changed our focus to concentrate on our Next Generation Chemotherapy drugs, with the intention of seeking partnering opportunities for our non-oncology assets. As part of that transition, we have been evaluating how to best position Processa for long-term success and determined now is the right time to transition to our next stage of corporate leadership. Given his oncology and drug development expertise, Dr. Young has decided moving full-time to drug development will allow him to focus on advancing the development of our Next Generation Chemotherapy drugs to subsequent FDA approval.”

To view the full press release, visit https://ibn.fm/xqjIM

About Processa Pharmaceuticals Inc.

Processa is a clinical stage pharmaceutical company focused on developing the Next Generation Chemotherapy drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but will also increase the probability of FDA approval for its Next Generation Chemotherapy drugs. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. Its approach to drug development is based on more than 30 years of drug development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. Using its proven Regulatory Science Approach, Processa has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s Next Generation Chemotherapy drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients who will benefit from each Next Generation Chemotherapy drug. Currently in its pipeline are three Next Generation Chemotherapy drugs: Next Generation Capecitabine (“PCS6422” and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers), Next Generation Gemcitabine (“PCS3117” to treat pancreatic, lung, ovarian, breast, and other cancers), and Next Generation Irinotecan (“PCS11T” to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L) today announced positive results of a preliminary feasibility study (“PFS”) for the company’s 100%-owned South West Arkansas (“SWA”) Project. Among the highlights, the company reported base production of 30,000 tonnes per annum (“tpa”) battery-quality lithium hydroxide monohydrate (“LHM”); upside case of 35,000 tpa. “The robust economics from the South West Arkansas Project PFS showcase its incredible potential,” said Dr. Andy Robinson, president and COO of Standard Lithium. “Our exploration program in the first half of this year yielded significantly improved lithium concentrations and grew the total resource to 1.8 million tonnes of lithium carbonate equivalent. The upgraded resource underpins an operating life of at least 20 years at competitive costs.”

To view the full press release, visit https://ibn.fm/KLnXe

About Standard Lithium Ltd.

Standard Lithium is a leading near-commercial lithium development company with a portfolio of projects in progress. The company’s flagship Lanxess and South West Arkansas projects are located in southern Arkansas near the Louisiana state line. The company is focused on the evaluation and testing of commercial lithium extraction and purification from brine sourced from approximately 180,000 acres of leases across these two projects. The company operates a first-of-a-kind industrial-scale DLE Demonstration Plant at the Lanxess South Plant. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. A feasibility study and front-end engineering study for its first commercial scale lithium extraction plant located at the Lanxess South Plant (Phase 1A of the Lanxess Project) commenced in September 2022. Standard Lithium is targeting completion of a feasibility study for the South West Arkansas Project by the end of 2024. Concurrently, the company is pursuing resource development of other projects in the Smackover Formation in East Texas, as well as approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. Standard Lithium is jointly listed on the TSX Venture Exchange and the NYSE American under the trading symbol SLI and on the Frankfurt Stock Exchange under the symbol S5L. For more information, please visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTC: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, is adding TiNDLE Chicken to its ecommerce fulfillment solutions. The leading plant-based chicken, TiNDLE is made by Singapore-founded food tech start-up TiNDLE Foods, and is the latest in a growing number of brands PlantX has added to its online offerings. The move marks the debut of the full range of TiNDLE Foods being available online for shipment across the United States. TiNDLE chicken offers the distinct aroma, taste and texture of chicken and is made with non-GMO, plant-based ingredients; the product is similar in taste, texture and aroma to chicken.

“We recently completed a widely successful multimonth collaboration with TiNDLE where we transformed our pop-up market in Venice Beach, California, into a TiNDLE destination, including a redesign of the store facade into a custom mural painted by local artist Jules Muck,” said PlantX Life Lorne Rapkin in the press release. “The pop-up featured the new TiNDLE Chicken retail items in a variety of prepared dishes including a Chicken Parm Sandwich, Fried Chicken Sandwich, Chicken & Waffles, Buffalo Chicken Wrap and Sticky Wings. It has been amazing to work with TiNDLE and see firsthand the popularity of their products, and we are excited for this next step of becoming their direct-to-consumer arm to bring their products to household across America.”

To view the full press release, visit https://ibn.fm/aq6eu

About PlantX Life Inc.

PlantX is committed to being the digital face of the plant-based community as well as the one-stop shop for plant-based products. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. PlantX also has other brands in the PlantX portfolio, including a juice brand, a coffee company, a plant shop and brick-and-mortar grocery stores. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. PlantX’s digital presence eliminates entry barriers for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF) today announced its entry into an agreement with Prof. Avi Domb of the Hebrew University, School of Pharmacy, and with Prof. Elyad Davidson, of Hadassah Hospital, to perform a clinical pharmacology (“PK”) study of the uptake of cannabidiol (“CBD”) in a formulation that can be delivered as an oral pill. The PK study will seek to determine how much CBD is taken up into the blood of volunteers. “We believe that the new pill formulation has the potential to dramatically improve the availability and absorption of CBD taken orally as a pill, and plan to facilitate clinical studies to test this,” said Prof. Sir Marc Feldmann, executive co-chairman of 180 Life Sciences. “If successful, we believe that this may significantly expand the use of CBD and derivatives and may permit their use in multiple conditions including, most importantly, pain (a huge unmet need where there are few safe drugs), anxiety and … weight management. Recent human studies have demonstrated that CBD can improve post-operative pain and might decrease opioid consumption, an important goal*. This is an exciting prospect and Prof. Domb’s team has a track record in formulating medications for therapeutic use.”

To view the full press release, visit https://ibn.fm/35DoI

About 180 Life Sciences Corp.

180 Life Sciences is a clinical stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy. The company’s current primary focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor).

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at http://ibn.fm/ATNF

*Talk by Michael J. Alaia, MD, FAAOS concerning the efficacy of an orally absorbed CBD tablet for postoperative pain relief following rotator cuff surgery. Presented at the 2022 American Academy of Orthopaedic Surgeons Annual Meeting.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen (NASDAQ: VTGN), a clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, today announced positive top-line results from its Phase 3 PALISADE-2 trial. The trial, to evaluate the efficacy, safety and tolerability of fasedienol (“PH94B”) nasal spray in adults diagnosed with social anxiety disorder (“SAD”), met its primary endpoint, with fasedienol demonstrating a statistically significant difference in average SUDS score during a public speaking challenge compared to placebo. The trial also met its secondary endpoint, demonstrating a statistically significant difference in the proportion of clinician-assessed responders between fasedienol and placebo as measured by the CGI-I scale.

“We are thrilled that these compelling top-line results from the Phase 3 PALISADE-2 trial confirm what was seen in the Phase 2 studies in social anxiety disorder and highlight the potential for fasedienol, with its novel and unique proposed mechanism of action, to transform what is possible for more than 25 million people living with social anxiety in the U.S. and millions more affected worldwide,” said Shawn Singh, chief executive officer of Vistagen. “As a new class of medicines, our pherine nasal spray pipeline holds the potential to transform the treatment landscape across numerous therapeutic areas. At the head of that class, fasedienol’s potential, as demonstrated in this Phase 3 trial, sets the stage for the first fundamentally new class of medicine for individuals living with SAD in more than 20 years.”

To view the full press release, visit https://ibn.fm/iKTYL

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. Vistagen is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those currently available for the treatment of anxiety, depression and multiple CNS disorders. Vistagen’s pipeline includes six clinical-stage product candidates, including fasedienol (“PH94B”), itruvone (“PH10”), “PH15,” “PH80,” and “PH284,” each an investigational agent belonging to a new class of drugs known as pherines, as well as “AV-101,” which is an oral prodrug antagonist of the N-methyl-D-aspartate receptor (“NMDAR”). Pherines are administered as low microgram dose level nasal sprays and are designed with a novel mechanism of action that activates chemosensory neurons in the nasal cavity and can beneficially impact key neural circuits in the brain without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global vendor of push-to-talk over cellular (“PoC”) devices and cellular signal booster systems, has announced that Tango Tango, a leading provider of critical push-to-talk (“PTT”) communications solutions and an existing reseller of Siyata products, will offer its public safety-focused app on Siyata Mobile’s SD7 Handset along with related SD7 accessories. “We are excited to expand our relationship with Tango Tango and for them to market our industry leading SD7 Handset equipped with their proprietary PTT application,” said Marc Seelenfreund, CEO of Siyata. “Tango Tango primarily serves the first responder, education and health care markets, and its application integrates seamlessly with our SD7 Handset providing us with yet another channel to grow our business and increase our market share.”

To view the full press release, visit https://ibn.fm/2Af9j

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation push-to-talk over cellular devices, cellular booster systems and video monitoring solutions. Its portfolio of in-vehicle and rugged devices enables first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise-grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signals in remote areas, inside structural buildings where signals are weak, and within vehicles for the maximum cellular signal strength possible. For its video monitoring system, Siyata integrates software that it licenses with off-the-shelf hardware providing its customers with an integrated advanced camera system for management and visual monitoring of their fleet vehicles. Siyata’s common shares and previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. For more information about the company, visit www.SiyataMobile.com and UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA          

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• FEXD understands the changing dynamics and the growing preference for digital payments
• Through its aggressive yet strategic acquisition approach, FEXD is offering solutions that make it easy to move money across borders
• By prioritizing developing nations and creating systems and infrastructure unique to the needs of customers in these countries, FEXD is addressing the issue of gross unmet mobile needs
• This reflects the company’s commitment to its mission and to creating shareholder value

Fintech Ecosystem Development (NASDAQ: FEXD), a special purpose acquisition company (“SPAC”), is focused on the changing consumer landscape and how digital payments are shaping the way people transact. In response, the company is pushing for the creation and proliferation of much-needed scalable access to systems and infrastructure that facilitate cashless payments, ultimately playing an integral role in advancing a cashless society, both in the U.S. and around the world.

According to Pew Research, it was estimated that, in 2022, two-fifths of Americans used no cash. Additional studies showed that 11% of U.S. adults have stopped using cash, up from 5% five years ago, with the average number of cash payments falling from 26% in 2019 to 20% in…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, is reporting on its first quarter 2023 operating results for the period ended March 31, 2023. Highlights of the report included the finalization of a VIA transaction in January; key partnerships announced by subsidiary Energica to advance all-electric solutions for aviation, marine, and off-road uses; the expansion of subsidiary Solectrac’s dealer network and subsidy program for all-electric tractors; the partnership between US Hybrid and Mi-Jack to develop hydrogen-powered rubber tire gantry crane; and the collaboration between US Hybrid and Global Environmental Products to make 18 zero-emission street sweepers for Caltrans. In addition, the report noted that Ideanomics has consolidated all energy and charging solutions under one brand: WAVE Charging. Key numbers from the report include revenues of $10.6 million and gross profit for the quarter totaling ($0.6) million. The company reported that revenue was primarily down “due to a decrease in revenue from Timios the title & escrow services business, and a decrease in revenue from the China-based EV resale business.” The report also noted that, during the first quarter, IDEX began executing on its commitment to shareholders to exit noncore businesses, including the sale of Timios and the shutdown of the company’s Justly financial services business.

To view the full press release, visit https://ibn.fm/zSGp0

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles and charging technology with design, implementation and financial services, the company provides the completeness of solutions needed for the commercial world to commit to an EV future. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based critical minerals company, reported its financial results for the quarter ended June 30, 2023. Highlights of the report included a “robust” balance sheet showing working capital of $134.36 million, up from $116.97 million in December 2022 ); a net loss of $4.89 million, or $0.03 per share; and an inventory of 766,000 pounds of finished U3O8, 906,000 pounds of finished V2O5, and 37 MT of finished high-purity, partially separated mixed REE carbonate, with an additional 403,000 pounds of U3O8 as raw materials and work-in-progress inventory. The report also noted that, regarding uranium, UUUU sold 80,000 pounds of U3O8 to a major U.S. nuclear utility for $4.34 million; the company anticipates sell an additional 180,000 pounds of U3O8 for an estimated $54–$58 per pound, resulting in an estimated 46%–50% gross margin. Regarding REEs, UUUU produced approximately 99 MT of high-purity, partially separated mixed RE carbonate from monazite during the quarter, and the company also noted in the report that it is continuing to advance its program to evaluate the potential to recover radioisotopes from its process streams for use in emerging targeted alpha therapy cancer therapeutics.

In addition, the company announced that it is hosting a conference call and webcast today at 4 p.m. ET to discuss its second-quarter results as well as the outlook for the remainder of 2023; the call will also provide an overview of UUUU’s uranium, rare earths, vanadium and medical isotopes initiatives. Those interesting in accessing the call can dial 1-888-664-6392, and an operator will connect you to the call. A replay of the call will be available until Aug. 21, 2023; interested parties can dial 1-888-390-0541 or 1-416-764-8677 and enter the replay code 682077#.

“Energy Fuels continued to make excellent progress on all aspects of our core uranium and rare earth businesses during Q2 2023,” said Energy Fuels president and CEO Mark S. Chalmers in the press release. “We completed the sale of 80,000 pounds of uranium to one of our utility customers under one of our long-term contracts. We expect to make another sale of 180,000 pounds of uranium under another long-term contract later this year. . . . Energy Fuels also remains on schedule to complete ‘phase 1’ of our rare earth project at the White Mesa Mill in Utah, which involves modifications and enhancements to the mill’s existing SX building that are expected to have the capacity to produce approximately 800–1,000 metric tons of separated NdPr oxide per annum. . . .Later this year, we expect to begin pilot work on ‘heavy’ rare earth separation, including the production of separated dysprosium and terbium oxides. At the same time, we continue to move our Bahia Rare Earth Project in Brazil forward toward production and to secure additional sources of monazite supply to process at the Mill for rare earth production. . . . To say Energy Fuels continues to make rapid and extraordinary progress on creating a ‘critical mineral hub’ in Utah to help the United States ‘reshore’ critical mineral capabilities required for many advanced clean energy, defense and other technologies is truly an understatement.”

To view the webcast, visit https://ibn.fm/pjZqI

To view the full press release, visit https://ibn.fm/joBHQ

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based critical minerals company. As the leading producer of uranium in the United States, Energy Fuels mines uranium and produces natural uranium concentrates that are sold to major nuclear utilities for the production of carbon-free nuclear energy. Energy Fuels recently began production of advanced rare earth element (“REE”) materials, including mixed REE carbonate, and plans to produce commercial quantities of separated REE oxides in the future. Energy Fuels also produces vanadium from certain of its projects, as market conditions warrant, and is evaluating the recovery of radionuclides needed for emerging cancer treatments. Its corporate offices are in Lakewood, Colorado, and substantially all its assets and employees are in the United States. Energy Fuels holds two of America’s key uranium production centers: the White Mesa Mill in Utah and the Nichols Ranch in-situ recovery (“ISR”) project in Wyoming. The White Mesa Mill is the only conventional uranium mill operating in the country today, has a licensed capacity of more than 8 million pounds of U3O8per year, has the ability to produce vanadium when market conditions warrant, as well as REE products, from various uranium-bearing ores. The Nichols Ranch ISR project is on standby and has a licensed capacity of 2 million pounds of U3O8per year. The company recently acquired the Bahia Project in Brazil, which is believed to have significant quantities of titanium (ilmenite and rutile), zirconium (zircon) and REE (monazite) minerals. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101-compliant uranium resource portfolios in the United States and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork